Showing results (91-100 of 172) with videos related to
Sort By:
Pageof 18
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapyTeh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, et al.European Journal of Gastroenterology & Hepatology|October 16, 2003
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resectionTeh-Ia Huo, Jaw-Ching Wu, Wing-Yu Lui, et al.Plos One|June 28, 2013
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral TherapyChien-Wei Su, Yu-Wei Chiou, Yi-Hsuan Tsai, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2008
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 yearsChien-Wei Su, Hung-Hsu Hung, Teh-Ia Huo, et al.Journal of Surgical Oncology|May 29, 2007
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillanceTeh-Ia Huo, Cheng-Yuan Hsia, Chi-Jen Chu, et al.World Journal of Surgery|February 13, 2004
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrenceTeh-Ia Huo, Wing-Yu Lui, Jaw-Ching Wu, et al.Clinical and Translational Gastroenterology|January 19, 2024
Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular CarcinomaChun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, et al.Scientific Reports|May 18, 2022
Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor ruptureChun-Yang Lee, Gar-Yang Chau, Cheng-Yi Wei, et al.Hepatology International|November 6, 2021
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelinesWei Teng, Ting-Tsung Chang, Hwai-I Yang, et al.Scientific Reports|February 18, 2017
The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinomaWei-Yao Hsieh, Ping-Hsien Chen, I-Yen Lin, et al.Pageof 18